Cannabis News

Trulieve CEO Kim Rivers to Give Keynote Address at Benzinga Cannabis Capital Conference

Trulieve Cannabis Corp. CEO Kim Rivers will be speaking at 3:05 p.m. EST , February 25th at Benzinga's Virtual Cannabis Capital Conference Guzman

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a United States-based leading medical cannabis company, announced today that CEO Kim Rivers will be speaking at the Benzinga Cannabis Capital Conference, Thursday, February 25, 2020 at 3:05 p.m. EST . The conference will feature an interactive forum of live presentations from top CEOs, investors, and leaders in the cannabis space.

For more information regarding registering for the Benzinga conference please visit: https://events.benzinga.com/ccc-free-registration

About Trulieve
Trulieve is primarily a vertically integrated "seed-to-sale" company in the U.S. and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida , as well as directly to patients via home delivery. Trulieve also operates in California, Massachusetts and Connecticut. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX Best Market under the symbol TCNNF.

To learn more about Trulieve, visit www.Trulieve.com .

Cision View original content: http://www.prnewswire.com/news-releases/trulieve-ceo-kim-rivers-to-give-keynote-address-at-benzinga-cannabis-capital-conference-301233734.html

SOURCE Trulieve Cannabis Corp.

News Provided by PR Newswire via QuoteMedia

The Conversation (0)

Goodness Growth Holdings Announces Fourth Quarter and Full Year 2022 Results

2022 revenue of $74.6 million increased 37.1% YOY and 57.8% excluding discontinued operations –

– Q4 revenue of $19.0 million increased 39.4% YoY and 55.8% excluding discontinued operations –

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Goodness Growth Holdings Announces Amended Credit Facility and Governance Updates

Amended credit facility with Green Ivy removes amortization schedule and extends maturity date –

– Company in advanced discussions to finalize separate $10 million convertible loan financing –

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Ziad Ghanem Promoted to Chief Executive Officer of TerrAscend

TerrAscend Corp. ("TerrAscend'' or the "Company") (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced that Ziad Ghanem has been promoted to the role of Chief Executive Officer ("CEO") effective immediately, in addition to his existing role as President of the Company. Mr. Ghanem was most recently TerrAscend's President and Chief Operating Officer ("COO") and was elected to the new role of CEO unanimously by TerrAscend's Board of Directors.

TerrAscend Corp. Logo (CNW Group/TerrAscend)

Mr. Ghanem has served as President and COO at TerrAscend since January 2022 . In that role he helped guide the company to record year-over-year revenue growth managing the daily operations at one of the strongest operating footprints in the industry. Throughout his 20-year career, Mr. Ghanem held several senior leadership positions across the pharmaceutical, healthcare services, cannabis and retail industries, including serving as President of Parallel, a vertically integrated, multi-state cannabis operator. Before entering the cannabis industry, Mr. Ghanem gained more than 15 years of experience at Walgreens and Walgreens Boots Alliance in multiple areas including operations, strategy and innovation. Mr. Ghanem holds a Doctor of Pharmacy degree from the University of Houston .

"Ziad is a phenomenal leader who has been instrumental in driving improvements across the organization. Over Ziad's first 15 months with TerrAscend he has become a trusted friend, and my respect for his leadership, judgment and grit has grown immensely," said Jason Wild , Executive Chairman of TerrAscend. "He has done an outstanding job as President and COO, and I can't imagine a more qualified person to assume the CEO role. I am grateful to have found someone who shares my passion for TerrAscend's long term success. I look forward to continuing our strong working relationship in the future."

"We are building something special at TerrAscend while keeping our team members and customers at the center of each decision we make," added Mr. Ghanem. Over the last 15 months, I have witnessed a team with a level of commitment, passion and determination that is beyond impressive. I am deeply grateful to the Board for their trust in me, and I am particularly thankful to Jason Wild for being my biggest supporter and mentor."

About TerrAscend

TerrAscend is a leading North American cannabis operator with vertically integrated operations in Pennsylvania , New Jersey , Maryland , Michigan and California and retail operations in Canada . TerrAscend operates The Apothecarium and Gage dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend's cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns several synergistic businesses and brands including Gage Cannabis, The Apothecarium, Ilera Healthcare, Kind Tree, Legend, State Flower, and Valhalla Confections. For more information visit www.terrascend.com .

Caution Regarding Cannabis Operations in the United States

Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States . Cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis in the United States . Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable US federal money laundering legislation.

While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve TerrAscend of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against TerrAscend. The enforcement of federal laws in the United States is a significant risk to the business of TerrAscend and any proceedings brought against TerrAscend thereunder may adversely affect TerrAscend's operations and financial performance.

Forward Looking Information

This news release contains "forward-looking information" within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, "may", "would", "could", "will", "likely", "expect", "anticipate", "believe, "intend", "plan", "forecast", "project", "estimate", "outlook" and other similar expressions. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management's experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment, and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to, current and future market conditions; risks related to federal, state, provincial, territorial, local and foreign government laws, rules and regulations, including federal and state laws in the United States relating to cannabis operations in the United States ; and the risk factors set out in the Company's most recently filed MD&A, filed with the Canadian securities regulators and available under the Company's profile on SEDAR at www.sedar.com and in the section titled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2022 filed with the Securities and Exchange Commission on March 16, 2023 .

The statements in this press release are made as of the date of this release. TerrAscend disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

SOURCE TerrAscend

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2023/31/c7916.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Aurora Repurchases ~$47 Million Principal Amount of Convertible Notes, Saving $2.6 Million in Annualized Interest Payments; Balance Sheet Remains Among Strongest in Canadian Cannabis Industry

NASDAQ | TSX: ACB

Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced that it has repurchased an aggregate of approximately $46.6 million ( US$34.3 million ) principal amount of its convertible senior notes ("Notes") at a total cost, including accrued interest, of $45.6 million ( US$33.6 million ) in cash, saving $2.6 million in annualized interest payments. Following completion of this repurchase, Aurora will have approximately $103 million ( US$76 million ) of Notes outstanding.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Goodness Growth Holdings Reschedules Release of Fourth Quarter and Full Year 2022 Results to March 31, 2023

Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a cannabis company committed to providing safe access, quality products and great value to its customers, today announced that it has rescheduled the release of its financial results for its fourth quarter and full year ended December 31, 2022 to Friday, March 31, 2023 after the market closes.

Goodness Growth management will host a conference call with the investment community the following business day, Monday, April 3, 2023 at 8:30 a.m. ET (7:30 a.m. CT) to discuss its results. Interested parties may attend the conference call by dialing 1-888-414-4585 (Toll-Free) (US and Canada) or 1-646-960-0331 (Toll) (International) and referencing conference ID number 8663261.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Curaleaf Announces Acquisition of Deseret Wellness

Transaction Strengthens Curaleaf's Presence in Utah as State's Largest Retail Operator

Upon Close, the Company's Retail Footprint Will Increase to Four Dispensaries in Utah and 150 Nationwide

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×